| Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2). | |
| | |
MedLine Citation:
|
PMID: 20850089 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: This study sought to evaluate second-generation drug-eluting stent (DES) thrombosis in clinical practice. BACKGROUND: First-generation DES are associated with a significant incidence of late thrombosis. There is paucity of data regarding real practice late thrombosis incidence and predictors with second-generation DES, zotarolimus-eluting stent (ZES), and everolimus-eluting stents (EES). METHODS: A prospective, large-scale, non-industry-linked multicenter registry was designed. Complete clinical-procedural data and systematic follow-up of all patients treated with these stents was reported in a dedicated registry supported by the Spanish Working Group on Interventional Cardiology. RESULTS: From 2005 to 2008, 4,768 patients were included in 34 centers: 2,549 treated with ZES, and 2,219 with EES. The cumulative incidence of definite/probable thrombosis for ZES was 1.3% at 1 year and 1.7% at 2 years and for EES 1.4% at 1 year and 1.7% at 2 years (p = 0.8). The increment of definite thrombosis between the first and second year was 0.2% and 0.25%, respectively. In a propensity score analysis, the incidence remained very similar. Ejection fraction (adjusted hazard ratio [HR]: 0.97; 95% confidence interval [CI]: 0.95 to -0.99; p = 0.008), stent diameter (adjusted HR: 0.37; 95% CI: 0.17to 0.81; p = 0.01) and bifurcations (adjusted HR: 2.1; 95% CI: 1.14 to 3.7; p = 0.02) emerged as independent predictors of thrombosis. In the subgroup of patients with bifurcations, the use of ZES was independently associated with a higher thrombosis rate (adjusted HR: 4; 95% CI: 1.1 to 13; p = 0.03). CONCLUSIONS: In a real practice setting, the incidence of thrombosis at 2 years with ZES and EES was low and quite similar. The incidence of very late thrombosis resulted lower than was reported in registries of first-generation DES. In the subset of bifurcations, the use of ZES significantly increased the risk of thrombosis. |
| | |
Authors:
|
José M de la Torre Hernández; Fernando Alfonso; Federico Gimeno; Jose A Diarte; Ramón Lopez-Palop; Armando Pérez de Prado; Fernando Rivero; Juan Sanchis; Mariano Larman; Jose F Diaz; Jaime Elizaga; Javier Martín Moreiras; Alfredo Gomez Jaume; José M Hernández; Josepa Mauri; Angel Sánchez Recalde; Juan A Bullones; Jose R Rumoroso; Bruno García Del Blanco; Jose A Baz; Francisco Bosa; Javier Botas; Felipe Hernández; |
Related Documents
:
|
22009909 - Arthroscopically assisted treatment of adolescent knee joint tuberculosis. 11340009 - Intracoronary radiation with gamma wire inhibits recurrent in-stent restenosis. 21956049 - Long-term results of arthroscopic labral debridement: predictors of outcomes. 21658899 - Effect of light-emitting diode (led) therapy on the development of osteoarthritis (oa) ... 14713179 - Immediate sheath removal after pci using a femostop is feasible and safe. results of a ... 11721719 - Increased reperfusion by glycoprotein iib/iiia receptor antagonist administration in ca... 3522529 - A randomized trial of timentin and tobramycin versus piperacillin and tobramycin in feb... 1149489 - Short-term assessment of 0.1% hydrocortisone 17-butyrate ('locoid') in the treatment of... 23629789 - Intravitreal anti-vegf therapy for retinal macroaneurysm. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Multicenter Study |
Journal Detail:
|
Title: JACC. Cardiovascular interventions Volume: 3 ISSN: 1876-7605 ISO Abbreviation: JACC Cardiovasc Interv Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-09-20 Completed Date: 2011-03-01 Revised Date: 2012-08-29 |
Medline Journal Info:
|
Nlm Unique ID: 101467004 Medline TA: JACC Cardiovasc Interv Country: United States |
Other Details:
|
Languages: eng Pagination: 911-9 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Interventional Cardiology Department, Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario Marques de Valdecilla, Instituto de Formación e Investigación Marqués de Valdecilla, Santander, Spain. he1thj@humv.es |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Coronary Restenosis / epidemiology*, etiology Coronary Thrombosis / epidemiology*, etiology Drug-Eluting Stents / adverse effects* Female Follow-Up Studies Humans Incidence Male Prospective Studies Prosthesis Failure Registries* Risk Factors Spain / epidemiology |
| Investigator | |
Investigator/Affiliation:
|
Juan C Fernández Guerrero / ; José Moreu / ; Rafael Melgares / ; José M Vázquez / ; Adolfo Rincon / ; Jose D Cascon / ; Antonio Serra / ; Iñigo Lozano / ; Ramiro Trillo / ; Jesús M Jiménez Mazuecos / ; Eduardo Pinar / |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Acceptance, panic, and partial recovery the pattern of usage of drug-eluting stents after introducti...
Next Document: Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting s...